Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-06

Clinical Trial Update: the Use of Magnesium Sulfate for Prevention of Postspinal Shivering [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating magnesium sulfate for prevention of postspinal shivering has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Magnesium sulfate (magnesium sulfate)

Snippet

Sponsor: Cairo University | Conditions: Prevention of Postspinal Shivering | Phase 4 | Status: COMPLETED